Grant for Early-Stage Alzheimer's Therapeutics Research Funding in Tennessee (USA)
GrantID: 68778
Grant Funding Amount Low: $1
Deadline: Ongoing
Grant Amount High: $2,000,000
Summary
The grant program is offering a targeted challenge funding program for early phase human trials of potential therapies targeting Alzheimer's disease and related dementias. Both small for-profit and non-profit businesses are eligible for the program, and foreign candidates must provide proof of their yearly profits and net assets. Applications are accepted from organizations undertaking studies all over the world, with full-time staff or academic positions preferred...
Eligible applicants in Tennessee with a demonstrated commitment to Higher Education are encouraged to consider this funding opportunity. To identify additional grants aligned with your needs, visit The Grant Portal and utilize the Search Grant tool for tailored results.
Eligible Regions
Interests
Eligible Requirements
